Bipolar androgen therapy as platform for personalized medicine in castration-resistant prostate cancer
Abstract Background Bipolar androgen therapy (BAT) with supraphysiologic testosterone (SPT) could be a therapeutic platform to keep the “endocrine interference” going in men with castration resistant prostate cancer CRPC Davis ID., et al(N Engl J Med 38:121-31, 2019), Denmeade SR, Sena LA, Wang H, A...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer
2026-01-01
|
| Col·lecció: | Discover Oncology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/s12672-026-04441-2 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|